UCB and Parkinson's UK Collaboration Improve a Trial through Patient Involvement episode artwork

EPISODE · Oct 29, 2019 · 32 MIN

UCB and Parkinson's UK Collaboration Improve a Trial through Patient Involvement

from PharmaTalkRadio · host Conference Forum

In this podcast, hear a case study from the 2019 Patients as Partners EU conference on UCB and Parkinson's UK Working Together to Improve a Phase 2 Trial through Patient Involvement. In 2018, UCB and Parkinson’s UK co-developed a workshop to enable the UCB research team to work together with people affected by Parkinson’s to discuss and develop a potential phase 2 clinical trial. The aim of the workshop was to better understand people’s thoughts on clinical trials and get feedback on key features of the potential trial to maximise appropriateness, acceptability and success. In this session, attendees hear a multi-stakeholder perspective on the collaboration, including: • How the workshop was co-developed • Benefits and impact of patient involvement • Key challenges and solutions during the collaboration • Practical tips for industry and patient organisation collaborations Speakers: Natasha Ratcliffe, PhD, Research Involvement Manager, Parkinson’s UK Elaine Sutcliffe, Patient Advocate Kate Trenam, UK Patient Advocacy and Policy Manager, UCB   The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK. To learn more about patient centricity in R&D and the Patients as Partners EU program, visit theconferenceforum.org.

In this podcast, hear a case study from the 2019 Patients as Partners EU conference on UCB and Parkinson's UK Working Together to Improve a Phase 2 Trial through Patient Involvement. In 2018, UCB and Parkinson’s UK co-developed a workshop to enable the UCB research team to work together with people affected by Parkinson’s to discuss and develop a potential phase 2 clinical trial. The aim of the workshop was to better understand people’s thoughts on clinical trials and get feedback on key features of the potential trial to maximise appropriateness, acceptability and success. In this session, attendees hear a multi-stakeholder perspective on the collaboration, including: • How the workshop was co-developed • Benefits and impact of patient involvement • Key challenges and solutions during the collaboration • Practical tips for industry and patient organisation collaborations Speakers: Natasha Ratcliffe, PhD, Research Involvement Manager, Parkinson’s UK Elaine Sutcliffe, Patient Advocate Kate Trenam, UK Patient Advocacy and Policy Manager, UCB   The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK. To learn more about patient centricity in R&D and the Patients as Partners EU program, visit theconferenceforum.org.

NOW PLAYING

UCB and Parkinson's UK Collaboration Improve a Trial through Patient Involvement

0:00 32:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of PharmaTalkRadio?

This episode is 32 minutes long.

When was this PharmaTalkRadio episode published?

This episode was published on October 29, 2019.

What is this episode about?

In this podcast, hear a case study from the 2019 Patients as Partners EU conference on UCB and Parkinson's UK Working Together to Improve a Phase 2 Trial through Patient Involvement. In 2018, UCB and Parkinson’s UK co-developed a workshop to enable...

Can I download this PharmaTalkRadio episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!